News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
153 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Drug Development
Bay Area’s Global Blood Therapeutics Terminates Lung Disease Program
The company is shuttering its GBT440 program to treat idiopathic pulmonary fibrosis (IPF).
October 23, 2017
·
2 min read
·
Mark Terry
Deals
Exactech Goes Private in $625M Deal With TPG Capital
TPG Capital has acquired all the outstanding shares of Exactech common stock for $42 per share.
October 23, 2017
·
2 min read
·
Alex Keown
Business
George Scangos’ Bold Vision
The former Biogen CEO is making waves at his new venture, Vir Biotechnology.
October 23, 2017
·
1 min read
·
Karl Thiel
Biotech Bay
Shhhh.....There’s a New T-Cell Strategy
Rumor is there’s a new approach to fighting cancer in town.
October 23, 2017
·
1 min read
·
Karl Thiel
Policy
The IDO Battle Gets Ugly
Incyte has been at the forefront of the IDO race with its candidate epacadostat.
October 23, 2017
·
1 min read
·
Karl Thiel
FDA
Second CAR-T Approval Points to Exciting Times for Gene Therapy
Big pharmas are having a good year so far in terms of FDA approvals.
October 23, 2017
·
1 min read
·
Karl Thiel
Drug Development
FDA Calls Novartis’ Melanoma Combo Drug a Breakthrough
The FDA based its decision on data from the COMBI-AD Phase III trial.
October 23, 2017
·
2 min read
·
Mark Terry
Deals
Week in Review: WuXi AppTec Acquires US-Global Clinical CRO
WuXi AppTec, a China CRO/CMO, will acquire ResearchPoint Global, of Texas, a global clinical-stage contract research company, to extend the reach of its own clinical CRO coverage.
October 23, 2017
·
1 min read
AstraZeneca Gets in on ADC Therapeutics’ Mega $200M Funding Round
ADC Therapeutics announced it had raised $200M through an oversubscribed private placement.
October 23, 2017
·
3 min read
·
Mark Terry
Business
Eli Lilly to Invest $72M in Indianapolis Diabetes Manufacturing
In order to meet growing demand for insulin, pharma giant Eli Lilly said it will invest $72M to expand insulin manufacturing capabilities at one of its Indianapolis facilities.
October 23, 2017
·
2 min read
·
Alex Keown
Previous
2 of 16
Next
